1 / 4

Albumin Market

Albumin Market was worth USD 0.81 billion in 2022 and is poised to accumulate a valuation of USD 1.7 billion by 2030, registering a CAGR of 6.3% over the forecast duration of 2023-2030.

vikas94
Download Presentation

Albumin Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Albumin Market Statistical Data, And Forecast Assessment Till 2030 Albumin Market was worth USD 0.81 billion in 2022 and is poised to accumulate a valuation of USD 1.7 billion by 2030, registering a CAGR of 6.3% over the forecast duration of 2023-2030. The growing prevalence of liver disorders and rising usage of albumin during vaccine production are primarily augmenting the outlook of this marketplace. Additionally, increasing R&D activities in the field along with the surging usage of albumin induced injections during bypass surgeries are creating lucrative opportunities for the industry sphere to prosper. Also, rapid emergence of plant-based albumin components, increase in plasma collection activities, and growing immunoglobulin production across the globe are adding momentum to the expansion of this business sphere. Moreover, increasing cognizance regarding the benefits of this protein type and growing focus of market players to develop new products in the field are stimulating the overall market dynamics. On the contrary, stringent regulations pertaining to albumin use and adverse health effects caused by the component are hindering the remuneration scope of this industry sphere. Request Free Sample Copy of this Report@ https://wemarketresearch.com/reports/request- free-sample-pdf/albumin-market/831 Market Description Albumin is referred to as a type of naturally occurring protein secreted by the liver. This component is found in the blood plasma and it enters into the blood stream to prevent fluid leakage in tissues and blood vessels. Albumin is further equipped with the ability to transport pivotal elements such as enzymes, hormones, and vitamins throughout the human body. These proteins are generally water- soluble in nature and are also known for experiencing heat degeneration. Market Key Trends Efficacy of Albumin As A Multifunctional Excipient To Bolster Industry Development

  2. Albumin is a type of protein that offers various health based and commercial advantages. The efficacy of this component in regulating blood osmotic pressure is one of the major factors driving market growth. Moreover, it also prevents protein aggregation during their manufacture and transportation. Its high usage as a drug carrier during the treatment of ailments such as cancer, hepatitis, and diabetes is further adding traction to the industry expansion. Usage of Albumin During Vaccine Production To Augment Industry Outlook There has been a widespread adoption of albumin during the development of various vaccines. This is powered by the ability of this protein to prevent surface adsorption and check shear stress during the production process. Also, albumin is known to provide thermal stability to the developed vaccine samples. These factors are creating an upward trend for the market progression. Market Segmental Assessment By Type • Human Serum Albumin •Bovine Serum Albumin • Recombinant Albumin The human serum albumin segment is slated to amass notable gains over the anticipated timeline owing to its high efficacy is facilitating drug delivery. By Application •Drug Delivery • Therapeutics • Culture Media Ingredient • Vaccine Ingredient • Others By End User

  3. • Hospitals and Clinics • Pharmaceutical and Biotechnology Companies •Research Institutes • Others The pharmaceutical segment is likely to generate significant returns over the stipulated timeframe due to the widespread use of albumin is vaccine development. Market Competitive Hierarchy The prominent players defining the competitive terrain of this business vertical are Albumedix Ltd., Amgen, Baxalata Incorporated, Baxter International, Inc., Biotest AG, Celgene Corporation (BristolMyers Squibb Company), China Biologic Products, Inc., CSL Behring LLC, Grifols S.A., HiMedia Laboratories, Kedrion S.p.A., Medxbio Pte Ltd., Merck KGaA, Mitsubishi Tanabe Pharma, Novozymes Biotest AG, Octapharma AG, SERACARE LIFE SCIENCES, Sigma-Aldrich Corporation, Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc., Ventria Bioscience Inc., and Others. Secure a copy of the premium research report@ https://wemarketresearch.com/purchase/albumin-market/831?license=single About We Market Research: WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep-rooted market studies and insightful analysis of different markets. Contact Us: We Market Research Phone: +1(650)-666-4592 Email: sales@wemarketresearch.com Web: https://wemarketresearch.com/

More Related